In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...

People with chronic kidney disease (CKD) who require dialysis may qualify for Medicare and other financial assistance. Other sources of support include state and organizational programs and ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

The product is also indicated for the treatment ... no additional clinical trials were needed to expand the indication to include CKD patients as a bridging approach was implemented using ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

eGFR is calculated using a simple blood test to measure creatinine, a waste product. Higher creatinine levels generally correlate with lower eGFR, indicating reduced kidney function. CKD is ...

CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and ...

“The KDIGO 2024 guideline navigates clinicians through the identification, improved evaluation, and targeted treatment and management of persons with CKD,” the authors write. “Evaluation of ...